Tonghua Dongbao Pharmaceutical Co Ltd

SHG:600867 China Drug Manufacturers - Specialty & Generic
Market Cap
$2.41 Billion
CN¥17.67 Billion CNY
Market Cap Rank
#6357 Global
#960 in China
Share Price
CN¥9.02
Change (1 day)
-1.42%
52-Week Range
CN¥7.06 - CN¥9.27
All Time High
CN¥23.57
About

Tonghua Dongbao Pharmaceutical Co., Ltd. researches, develops, produces, and markets pharmaceuticals in China. It offers human insulin injections; insulin glargine injections; insulin aspart injections; liraglutide injections; and proprietary Chinese medicine. The company also provides insulin pen and pen needles; and chronic disease management platform, a diabetes management platform for drug tr… Read more

Tonghua Dongbao Pharmaceutical Co Ltd (600867) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.009x

Based on the latest financial reports, Tonghua Dongbao Pharmaceutical Co Ltd (600867) has a cash flow conversion efficiency ratio of 0.009x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥62.99 Million) by net assets (CN¥7.14 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Tonghua Dongbao Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Tonghua Dongbao Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Tonghua Dongbao Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tonghua Dongbao Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Tonghua Dongbao Pharmaceutical Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Tonghua Dongbao Pharmaceutical Co Ltd from 1998 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥6.40 Billion CN¥459.74 Million 0.072x -39.83%
2023-12-31 CN¥7.22 Billion CN¥861.52 Million 0.119x -9.40%
2022-12-31 CN¥6.55 Billion CN¥863.09 Million 0.132x -27.75%
2021-12-31 CN¥6.22 Billion CN¥1.13 Billion 0.182x -14.95%
2020-12-31 CN¥5.56 Billion CN¥1.19 Billion 0.214x -6.77%
2019-12-31 CN¥5.01 Billion CN¥1.15 Billion 0.230x +24.18%
2018-12-31 CN¥4.73 Billion CN¥876.94 Million 0.185x -12.56%
2017-12-31 CN¥4.54 Billion CN¥961.19 Million 0.212x +15.15%
2016-12-31 CN¥3.95 Billion CN¥725.76 Million 0.184x +54.81%
2015-12-31 CN¥2.48 Billion CN¥294.58 Million 0.119x +24.69%
2014-12-31 CN¥2.16 Billion CN¥205.89 Million 0.095x -13.08%
2013-12-31 CN¥2.02 Billion CN¥221.06 Million 0.110x +12.35%
2012-12-31 CN¥1.99 Billion CN¥194.32 Million 0.098x +468.21%
2011-12-31 CN¥2.08 Billion CN¥-55.07 Million -0.027x -128.63%
2010-12-31 CN¥1.73 Billion CN¥160.40 Million 0.093x -9.39%
2009-12-31 CN¥1.63 Billion CN¥166.20 Million 0.102x +58.67%
2008-12-31 CN¥1.43 Billion CN¥92.31 Million 0.064x -18.33%
2007-12-31 CN¥1.53 Billion CN¥120.94 Million 0.079x -36.33%
2006-12-31 CN¥1.28 Billion CN¥158.00 Million 0.124x +80.01%
2005-12-31 CN¥1.34 Billion CN¥92.23 Million 0.069x +592.91%
2004-12-31 CN¥1.33 Billion CN¥13.17 Million 0.010x -69.43%
2003-12-31 CN¥1.40 Billion CN¥45.51 Million 0.032x +38.36%
2002-12-31 CN¥1.36 Billion CN¥31.99 Million 0.023x -72.51%
2001-12-31 CN¥1.38 Billion CN¥117.73 Million 0.085x +317.87%
2000-12-31 CN¥1.43 Billion CN¥29.12 Million 0.020x +130.19%
1999-12-31 CN¥1.40 Billion CN¥-95.09 Million -0.068x +71.02%
1998-12-31 CN¥928.90 Million CN¥-216.98 Million -0.234x --